NEPHROS INC's ticker is NEPH and the CUSIP is 640671400. A total of 17 filers reported holding NEPHROS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83,000 | -6.7% | 56,710 | 0.0% | 0.00% | – |
| Q2 2023 | $89,000 | +48.3% | 56,710 | +1.8% | 0.00% | – |
| Q1 2023 | $60,000 | -6.2% | 55,710 | 0.0% | 0.00% | – |
| Q4 2022 | $64,000 | +25.5% | 55,710 | 0.0% | 0.00% | – |
| Q3 2022 | $51,000 | -40.0% | 55,710 | 0.0% | 0.00% | – |
| Q2 2022 | $85,000 | -65.3% | 55,710 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $245,000 | -25.3% | 55,710 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $328,000 | -32.8% | 55,710 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $488,000 | -13.6% | 55,710 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $565,000 | +52.7% | 55,710 | 0.0% | 0.00% | +100.0% |
| Q1 2021 | $370,000 | -22.6% | 55,710 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $478,000 | +52.7% | 55,710 | +28.9% | 0.00% | 0.0% |
| Q3 2020 | $313,000 | -13.5% | 43,210 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $362,000 | +32.6% | 43,210 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $273,000 | -36.5% | 43,210 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $430,000 | – | 43,210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parkman Healthcare Partners LLC | 199,724 | $1,987,000 | 0.57% |
| INGALLS & SNYDER LLC | 134,539 | $1,339,000 | 0.07% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 5,908 | $59,000 | 0.03% |
| B. Riley Wealth Advisors, Inc. | 14,254 | $142,000 | 0.01% |
| HighTower Advisors, LLC | 43,210 | $430,000 | 0.00% |
| BLAIR WILLIAM & CO/IL | 34,249 | $341,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 22,501 | $224,000 | 0.00% |
| DEUTSCHE BANK AG\ | 200 | $1,000 | 0.00% |
| BlackRock Inc. | 2,562 | $25,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 367 | $4,000 | 0.00% |